Export 130 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P. Almeida-Meza, Steptoe, A., and Cadar, D., Is Engagement in Intellectual and Social Leisure Activities Protective Against Dementia Risk? Evidence from the English Longitudinal Study of Ageing., J Alzheimers Dis, vol. 80, no. 2, pp. 555-565, 2021.
J. Antonio Allué, Sarasa, L., Izco, M., Pérez-Grijalba, V., Fandos, N., Pascual-Lucas, M., Ogueta, S., Pesini, P., and Sarasa, M., Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer's Disease., J Alzheimers Dis, vol. 53, no. 3, pp. 773-85, 2016.
S. L. Allison, Fagan, A. M., Morris, J. C., and Head, D., Spatial Navigation in Preclinical Alzheimer's Disease., J Alzheimers Dis, vol. 52, no. 1, pp. 77-90, 2016.
H. B. Allen, Alzheimer's Disease: Assessing the Role of Spirochetes, Biofilms, the Immune System, and Amyloid-β with Regard to Potential Treatment and Prevention., J Alzheimers Dis, vol. 53, no. 4, pp. 1271-6, 2016.
H. B. Allen, A Novel Approach to the Treatment and Prevention of Alzheimer's Disease Based on the Pathology and Microbiology., J Alzheimers Dis, vol. 84, no. 1, pp. 61-67, 2021.
G. Allali, Kern, I., Laidet, M., Armand, S., and Assal, F., Parkinsonism is a Phenotypical Signature of Amyloidopathy in Patients with Gait Disorders., J Alzheimers Dis, vol. 63, no. 4, pp. 1373-1381, 2018.
G. Allali, Garibotto, V., and Assal, F., Parkinsonism Differentiates Idiopathic Normal Pressure Hydrocephalus from Its Mimics., J Alzheimers Dis, vol. 54, no. 1, pp. 123-7, 2016.
J. I. Ali, Smart, C. M., and Gawryluk, J. R., Subjective Cognitive Decline and APOE ɛ4: A Systematic Review., J Alzheimers Dis, vol. 65, no. 1, pp. 303-320, 2018.
A. Alghamdi, Vallortigara, J., Howlett, D. R., Broadstock, M., Hortobágyi, T., Ballard, C., Thomas, A. J., O'Brien, J. T., Aarsland, D., Attems, J., Francis, P. T., and Whitfield, D. R., Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is associated with Cognitive Impairment in Lewy Body Dementia., J Alzheimers Dis, vol. 57, no. 2, pp. 373-386, 2017.
P. Alexopoulos, Soldatos, R., Kontogianni, E., Frouda, M., Aligianni, S. Loanna, Skondra, M., Passa, M., Konstantopoulou, G., Stamouli, E., Katirtzoglou, E., Politis, A., Economou, P., Alexaki, M., Siarkos, K., and Politis, A., COVID-19 Crisis Effects on Caregiver Distress in Neurocognitive Disorder., J Alzheimers Dis, vol. 79, no. 1, pp. 459-466, 2021.
C. Alexander, Zeithamova, D., Hsiung, G. - Y. R., Mackenzie, I. R., and Jacova, C., Decreased Prefrontal Activation during Matrix Reasoning in Predementia Progranulin Mutation Carriers., J Alzheimers Dis, vol. 62, no. 2, pp. 583-589, 2018.
M. Alegret, Peretó, M., Pérez, A., Valero, S., Espinosa, A., Ortega, G., Hernandez, I., Mauleón, A., Rosende-Roca, M., Vargas, L., Rodríguez-Gómez, O., Abdelnour, C., Berthier, M. L., Bak, T. H., Ruiz, A., Tárraga, L., and Boada, M., The Role of Verb Fluency in the Detection of Early Cognitive Impairment in Alzheimer's Disease., J Alzheimers Dis, vol. 62, no. 2, pp. 611-619, 2018.
M. S. Albert, DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., Snyder, P. J., Carrillo, M. C., Thies, B., and Phelps, C. H., The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease., Alzheimers Dement, vol. 7, no. 3, pp. 270-9, 2011.
R. B. Alam, Singleton, C. R., Aguiñaga, S., Chodzko-Zajko, W., Jahan, N. A., Oke, A., and Schwingel, A., Is Acculturation Associated with the Cognitive Performance of Older Hispanics?, J Alzheimers Dis, vol. 85, no. 2, pp. 535-544, 2021.
I. Alafuzoff and Libard, S., Mixed Brain Pathology Is the Most Common Cause of Cognitive Impairment in the Elderly., J Alzheimers Dis, vol. 78, no. 1, pp. 453-465, 2020.
O. M. Al-Janabi, Brown, C. A., Bahrani, A. A., Abner, E. L., Barber, J. M., Gold, B. T., Goldstein, L. B., Murphy, R. R., Nelson, P. T., Johnson, N. F., Shaw, L. M., Smith, C. D., Trojanowski, J. Q., Wilcock, D. M., and Jicha, G. A., Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension., J Alzheimers Dis, vol. 66, no. 3, pp. 1095-1104, 2018.
I. Akushevich, Yashkin, A. P., Kravchenko, J., Ukraintseva, S., Stallard, E., and Yashin, A. I., Time Trends in the Prevalence of Neurocognitive Disorders and Cognitive Impairment in the United States: The Effects of Disease Severity and Improved Ascertainment., J Alzheimers Dis, vol. 64, no. 1, pp. 137-148, 2018.
S. Akoudad, M Gurol, E., Fotiadis, P., Koudstaal, P. J., Hofman, A., M Ikram, A., Greenberg, S. M., and Vernooij, M. W., Cerebral Microbleeds and Cerebrovascular Reactivity in the General Population: The EDAN Study., J Alzheimers Dis, vol. 53, no. 2, pp. 497-503, 2016.
O. E. S. Akingbade, Gibson, C., Kalaria, R. N., and Mukaetova-Ladinska, E. B., Platelets: Peripheral Biomarkers of Dementia?, J Alzheimers Dis, vol. 63, no. 4, pp. 1235-1259, 2018.
C. Akiba, Nakajima, M., Miyajima, M., Ogino, I., Motoi, Y., Kawamura, K., Adachi, S., Kondo, A., Sugano, H., Tokuda, T., Irie, K., and Arai, H., Change of Amyloid-β 1-42 Toxic Conformer Ratio After Cerebrospinal Fluid Diversion Predicts Long-Term Cognitive Outcome in Patients with Idiopathic Normal Pressure Hydrocephalus., J Alzheimers Dis, vol. 63, no. 3, pp. 989-1002, 2018.
H. Akhter, Huang, W. - T., van Groen, T., Kuo, H. - C., Miyata, T., and Liu, R. - M., A Small Molecule Inhibitor of Plasminogen Activator Inhibitor-1 Reduces Brain Amyloid-β Load and Improves Memory in an Animal Model of Alzheimer's Disease., J Alzheimers Dis, vol. 64, no. 2, pp. 447-457, 2018.
C. S Akerman, Hossain, S., Shobo, A., Zhong, Y., Jourdain, R., Hancock, M. A., George, K., Breton, L., and Multhaup, G., Neurodegenerative Disease-Related Proteins within the Epidermal Layer of the Human Skin., J Alzheimers Dis, vol. 69, no. 2, pp. 463-478, 2019.
P. S. Aisen, Andrieu, S., Sampaio, C., Carrillo, M., Khachaturian, Z. S., Dubois, B., Feldman, H. H., Petersen, R. C., Siemers, E., Doody, R. S., Hendrix, S. B., Grundman, M., Schneider, L. S., Schindler, R. J., Salmon, E., Potter, W. Z., Thomas, R. G., Salmon, D., Donohue, M., Bednar, M. M., Touchon, J., and Vellas, B., Report of the task force on designing clinical trials in early (predementia) AD., Neurology, vol. 76, no. 3, pp. 280-6, 2011.
M. Ejaz Ahmed, Iyer, S., Thangavel, R., Kempuraj, D., Selvakumar, G. Pushpavath, Raikwar, S. P., Zaheer, S., and Zaheer, A., Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain., J Alzheimers Dis, vol. 60, no. 3, pp. 1143-1160, 2017.
S. Ahmed, Baker, I., Husain, M., Thompson, S., Kipps, C., Hornberger, M., Hodges, J. R., and Butler, C. R., Memory Impairment at Initial Clinical Presentation in Posterior Cortical Atrophy., J Alzheimers Dis, vol. 52, no. 4, pp. 1245-50, 2016.